Edwards Lifesciences Enterprise Value over EBITDA Trend

EW -- USA Stock  

USD 152.62  2.34  1.56%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Enterprise Value over EBITDA of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the ratio between Enterprise Value and [EBITDAUSD].
Enterprise Value over EBITDA10 Years Trend
Increasing
Stable
 Enterprise Value over EBITDA 
      Timeline 

Regression Statistics

Arithmetic Mean  20.71
Geometric Mean  19.70
Coefficient Of Variation  30.23
Mean Deviation  5.47
Median  24.09
Standard Deviation  6.26
Sample Variance  39.21
Range  16.48
R Value  0.18
Mean Square Error  41.80
R Squared  0.03099
Significance  0.58
Slope  0.31
Total Sum of Squares  431.35

Edwards Lifesciences Enterprise Value over EBITDA Over Time

2016-12-31  24.13 
2017-12-31  24.13 
2018-12-31  25.38 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Edwards Lifesciences Upcoming Company Events

Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">